We optimized H-Ala-Thr-Trp-Leu-Pro-Pro-Arg-OH (ATWLPPR) peptide-targeted silica-based nanoparticles to target the tumor vasculature through the vascular receptor neuropilin-1 (NRP-1) [14]. This evidence concerns the gene NRP1 and neoplasm.